Atezolizumab trials for Metastatic Lung Non-Small Cell Carcinoma

All Atezolizumab trials · All Metastatic Lung Non-Small Cell Carcinoma trials

Phase breakdown

Recruiting trials studying Atezolizumab for Metastatic Lung Non-Small Cell Carcinoma

• Diclofenac for the Treatment of Patients With Metastatic Non-small Cell Lung Cancer on Single Agent Immunotherapy
  NCT06731270 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• SX-682 and Atezolizumab for the Treatment of Advanced or Metastatic, Recurrent Non-small Cell Lung Cancer
  NCT07322341 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Vismodegib and Atezolizumab for the Treatment of Recurrent or Metastatic Non-Small Cell Lung Cancer
  NCT06616623 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials study Atezolizumab for Metastatic Lung Non-Small Cell Carcinoma?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.